Home » Topics » BioWorld Science

BioWorld Science
RSS

Treatment begins in phase II SHINE-1 study of scar reduction with EB-001

Feb. 9, 2018

Fujifilm and Takeda establish regenerative medicine collaboration to treat heart failure

Feb. 9, 2018

Phase III trials of peficitinib in rheumatoid arthritis meet primary endpoints

Feb. 9, 2018

FDA grants orphan drug designation to Xeris' ready-to-use, liquid-stable glucagon

Feb. 9, 2018

Bristol-Myers Squibb offers overview of fourth quarter 2017

Feb. 9, 2018

Lonza Pharma & Biotech and Denali Therapeutics partner on biologics

Feb. 9, 2018

Rexahn Pharmaceuticals to collaborate with Zhejiang Haichang Biotechnology on RX-0201

Feb. 9, 2018

uniQure presents further clinical data on AMT-060 for hemophilia B

Feb. 9, 2018

Significant reductions in LDL-cholesterol seen with MGL-3196 in phase II tiral

Feb. 9, 2018

Vifor prepares to begin phase I trial of oral ferroportin inhibitor VIT-2763

Feb. 9, 2018